VHL mutation rates were similar between eGFR groups (eGFR < 60 = 29% vs. eGFR > 60 = 43%, P = 0.51) and HTN history (HTN = 32% and no HTN = 50%; P = 0.32) but were significantly associated with race (B = 19% and W = 57.1%; P = 0.025; Fig. 1B), suggesting that race, but not differing frequencies of HTN and chronic kidney disease, accounts for the difference in VHL mutation frequency observed between AFR and EUR groups. The gene discussed is VHL; the disease is chronic kidney disease.